Syros Pharmaceuticals Inc (SYRS)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 244.49M | 205.32M | 180.98M | 147.8M | 168.17M | 134.73M | 106.72M | 85M |
流動資産合計 | 211.39M | 173.64M | 152.63M | 122.52M | 144.98M | 112.2M | 84.92M | 63.93M |
現金および同等物 | 167.47M | 104.77M | 115.44M | 112.22M | 139.53M | 83.52M | 78.96M | 58.28M |
非流動資産合計 | 44.37M | 31.67M | 28.35M | 25.28M | 30.49M | 22.53M | 21.8M | 21.06M |
負債合計 | 116.75M | 98.57M | 107.74M | 111.49M | 151.51M | 119.67M | 113.07M | 96.12M |
流動負債合計 | 30.78M | 23.55M | 28.38M | 28.39M | 36.68M | 37.3M | 24.52M | 28.39M |
非流動負債合計 | 126.62M | 114.14M | 120.3M | 122.51M | 149.39M | 112.08M | 129.49M | 108.81M |
普通株 | 20k | 20k | 20k | 21k | 26k | 26k | 26k | 27k |
留保所得 | -558.23M | -582.02M | -618.28M | -658.42M | -722.81M | -726.52M | -749.84M | -756.24M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 91.32M | 78.49M | 106.77M | 149.98M | 213.25M | 182.94M | 244.49M | 168.17M |
流動資産合計 | 85.51M | 73.16M | 101.73M | 114.51M | 178.56M | 136.59M | 211.39M | 144.98M |
現金および同等物 | 58.59M | 32.21M | 49.89M | 41.44M | 173.98M | 92.3M | 167.47M | 139.53M |
非流動資産合計 | 80.6M | 65.32M | 78.59M | 79.18M | 90.55M | 85.22M | 127.74M | 16.66M |
負債合計 | 10.72M | 13.16M | 28.18M | 70.79M | 122.7M | 97.72M | 116.75M | 151.51M |
流動負債合計 | 9.57M | 12.41M | 19.53M | 23.52M | 28.62M | 31.51M | 30.78M | 36.68M |
非流動負債合計 | 1.21M | 757k | 8.67M | 47.9M | 133.98M | 106.53M | 126.62M | 149.39M |
総資本 | 80.6M | 65.32M | 78.59M | 79.18M | 90.55M | 85.22M | 127.74M | 16.66M |
普通株 | 23k | 26k | 34k | 43k | 56k | 61k | 20k | 26k |
留保所得 | -101.26M | -155.27M | -217.55M | -292.98M | -377.02M | -463.58M | -558.23M | -722.81M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約